Rialto Wealth Management’s Biogen BIIB Stock Holding History

Rialto Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.13K	Buy	33 +15	+83%	+$2.87K	﹤0.01%	631
2026 Q1	$3.3K	Buy	18 +6	+50%	+$1.11K	﹤0.01%	695
2025 Q4	$2.11K	Buy	12 +3	+33%	+$490	﹤0.01%	728
2025 Q3	$1.26K	Buy	9 +3	+50%	+$406	﹤0.01%	845
2025 Q2	$754	Sell	6 -10	-63%	-$1.25K	﹤0.01%	963
2025 Q1	$2.19K	Buy	+16	New	+$2.29K	﹤0.01%	514

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rialto Wealth Management's BIIB Position: Q2 2026 in Review

Rialto Wealth Management increased its Biogen (BIIB) stake by 83% in Q2 2026, buying an estimated $2.87K and bringing the position to 33 shares worth $7.13K. The position accounts for ﹤0.01% of the portfolio, ranked #631.

Rialto Wealth Management first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Rialto Wealth Management held 33 shares of Biogen worth $7.13K as of Q2 2026.
Rialto Wealth Management bought 15 Biogen shares in Q2 2026, an estimated $2.87K.
Biogen made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #631 holding.
Rialto Wealth Management first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.